TrialEuropean journal of nuclear medicine and molecular imaging2008

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

Lisa Bodei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.